Masato Maeda Selected Research

epigallocatechin gallate (epigallocatechin-3-gallate)

12/2002

Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masato Maeda Research Topics

Disease

12	Neoplasms (Cancer) 01/2017 - 01/2002
6	Esophageal Squamous Cell Carcinoma 11/2005 - 01/2002
6	Lymphatic Metastasis 11/2005 - 01/2002
5	Neoplasm Metastasis (Metastasis) 08/2009 - 07/2002
5	Carcinogenesis 05/2004 - 01/2002
4	Carcinoma (Carcinomatosis) 05/2004 - 06/2002
3	Esophageal Neoplasms (Esophageal Cancer) 01/2007 - 07/2002
2	Inflammation (Inflammations) 10/2009 - 05/2003
2	Neoplasm Micrometastasis 11/2003 - 07/2002
1	Stomach Neoplasms (Stomach Cancer) 08/2022
1	Median Arcuate Ligament Syndrome 08/2022
1	Vomiting 05/2012
1	Abdominal Pain (Pain, Abdominal) 11/2010
1	Diarrhea 11/2010
1	Peptic Ulcer (Peptic Ulcers) 11/2010
1	Rupture 11/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010
1	Pathologic Constriction (Stenosis) 01/2010
1	Osteosarcoma (Osteogenic Sarcoma) 01/2010
1	Deglutition Disorders (Dysphagia) 01/2010
1	Colitis 10/2009
1	Pancreatic Pseudocyst 08/2009
1	Hemorrhage 08/2009
1	Lung Neoplasms (Lung Cancer) 01/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2008
1	Thrombosis (Thrombus) 01/2007
1	Barrett Esophagus (Barrett's Esophagus) 05/2004
1	Fibrosis (Cirrhosis) 05/2003
1	Cardiomegaly (Heart Hypertrophy) 05/2003
1	Infections 06/2002

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 11/2005 - 01/2002
3	Hematoxylin (Haematoxylon)IBA 11/2005 - 01/2002
3	Eosine Yellowish-(YS) (Eosin)IBA 11/2005 - 01/2002
3	ProstaglandinsIBA 05/2004 - 01/2002
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2004 - 01/2002
2	TeaIBA 10/2009 - 03/2003
2	squamous cell carcinoma-related antigenIBA 11/2005 - 07/2002
2	Keratins (Keratin)IBA 11/2003 - 07/2002
2	nitrosobenzylmethylamineIBA 03/2003 - 12/2002
1	SynaptophysinIBA 01/2017
1	AntiemeticsIBA 05/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2012
1	Granisetron (Kytril)FDA LinkGeneric 05/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2009
1	Dextrans (Dextran)FDA Link 10/2009
1	CollagenIBA 01/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2008
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 01/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2008
1	Indicators and Reagents (Reagents)IBA 11/2005
1	Complementary DNA (cDNA)IBA 12/2004
1	CCR7 ReceptorsIBA 08/2003
1	LigandsIBA 08/2003
1	E-SelectinIBA 07/2003
1	DystrophinIBA 05/2003
1	Proteins (Proteins, Gene)FDA Link 05/2003
1	Dinoprostone (PGE2)FDA Link 12/2002
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2002
1	Cyclin D1IBA 12/2002
1	aminophenylacetylleucine (APAL)IBA 07/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2002
1	human MMP12 proteinIBA 01/2002
1	Matrix Metalloproteinases (MMPs)IBA 01/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 05/2012 - 08/2009
3	Lymph Node Excision (Lymph Node Dissection) 01/2007 - 07/2002
2	Gastrectomy 08/2022 - 11/2010
2	Radiotherapy 01/2010 - 08/2009
1	Decompression 11/2010
1	Gastroenterostomy 11/2010
1	Pancreatectomy 08/2009
1	Splenectomy 08/2009
1	Esophagectomy 01/2007
1	Therapeutics 01/2007
1	Injections 03/2003